Brief: Shanghai Haohai Biological Technology Updates On Investigation Of Jiang Wei's Suspected Insider Trading Case
30/04/2026 13:43
April 30 (Reuters) - Shanghai Haohai Biological Technology Co Ltd 688366.SS: REFERS TO INVESTIGATION OF JIANG WEI'S SUSPECTED INSIDER TRADING CASE SHANGHAI MUNICIPAL PUBLIC SECURITY BUREAU RELEASE CONTROLLING SHAREHOLDER ON BAIL PENDING TRIAL MATTER WILL NOT HAVE ANY MATERIAL IMPACT ON DAY-TO-DAY OPERATION OF CO JIANG WEI DOES NOT HOLD ANY POSITION AS A DIRECTOR, SENIOR EXECUTIVE OR ANY OTHER POSITION IN CO Further company coverage: 688366.SS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shanghai Haohai Biological Technology
See all newsChina's Haohai Biological H1 revenue falls, partly hurt by end of Brighten Optix distribution
Brief: Shanghai Haohai Biological Technology Says Resignation Of Hou Yongtai As Exec Director, Chair
Brief: Shanghai Haohai Biological Technology Updates On Investigation Of Jiang Wei's Suspected Insider Trading Case
Brief: Shanghai Haohai Biological Technology Proposes To Elect Tian Min As An Additional Executive Director
Brief: Shanghai Haohai Biological Technology Posts Qtrly Net profit Attributable Of RMB73.6 Mln.